CELLINK to deliver custom facelifts with patented 3D bioprinting robots - 3D Printing Industry

Applicable only in its native Sweden, the firm's patent covers the uploading of a patient's 3D scan to an autonomous system, which uses this data to perform cosmetic filler procedures via bioprinting-armed robotics. Given that it's invention potentially provides patients with faster and more accurate plastic surgeries, CELLINK says that with further tweaking, it could find commercial applications moving forwards. "This invention shows our innovative research & development capabilities and passion for improving patient's outcomes, whether for cosmetic or reconstructive surgery," said Dr. Héctor Martínez, CTO of CELLINK. "This granted patent can potentially offer commercial opportunities for the CELLINK Group." "We foresee that this robotic system enables cutting-edge possibilities to deliver personalized aesthetic outcomes and we will continue to explore it."